Cloning and expression of the fusion protein of interleukin-2 and ESAT6 in Mycobacterium bovis Bacillus Calmette Gurin strain
Tuberculosis (TB) is the most common cause of death in infectious diseases; it is estimated that approximately 2 million people per year die of TB. The present available TB vaccine is a live attenuated strain, Mycobacterium bovis Bacillus Calmette Guérin (BCG). However, it has been shown that BCG ha...
Saved in:
Published in | Chinese medical journal Vol. 118; no. 9; pp. 762 - 765 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Tuberculosis (TB) is the most common cause of death in infectious diseases; it is estimated that approximately 2 million people per year die of TB. The present available TB vaccine is a live attenuated strain, Mycobacterium bovis Bacillus Calmette Guérin (BCG). However, it has been shown that BCG has variable protective efficacy, ranging from 0 to 85% in different clinical experiments. ^1Therefore, a new TB vaccine is urgently needed. |
---|---|
Bibliography: | R515 11-2154/R |
ISSN: | 0366-6999 2542-5641 |